Long-Term Peritoneal Indwelling Catheters for Malignant Ascites: A Retrospective Case Series of PleurX and Peritoneal Port.

Abstract

<b><i>Objectives:</i></b> To compare outcomes of PleurX and peritoneal port for malignant ascites. <b><i>Design:</i></b> Retrospective review of medical records was conducted. <b><i>Setting/Subjects:</i></b> Subjects were consecutive patients receiving PleurX or peritoneal port for malignant ascites in a center in Sydney, Australia. <b><i>Measurements:</i></b> Demographic data, complication rates, hospitalization rates, and survival were measured. <b><i>Results:</i></b> Sixteen cases were analyzed: 6 had peritoneal port (170 catheter days) and 10 had PleurX (477 catheter days). Complication rates were low with both drainage systems. Cellulitis rate was 33% (1.2 events/100 catheter days) for peritoneal port and 10% (0.2 events/100 catheter days) for PleurX. Hospital admission days were 27 days/100 catheter days for peritoneal port and 5.2 days/100 catheter days for PleurX. <b><i>Conclusions:</i></b> Both PleurX and peritoneal port seem feasible options in draining malignant ascites. Further research is needed to ascertain whether there are true differences in cellulitis/admission rates. Patient quality of life, experience, and preference should be included in future studies.